Iron is an essential mineral crucial for hemoglobin production, oxygen transport, energy metabolism, and cognitive function. It exists in two dietary forms: heme iron (from animal sources) with higher bioavailability, and non-heme iron (from plant sources) with lower absorption rates. Iron supplementation is primarily used to treat iron deficiency anemia, support athletic performance, and address fatigue, though both deficiency and excess can cause significant health issues.

Overview

Iron is a transition metal and essential trace element central to virtually all living organisms. In humans, approximately 65% of body iron resides in hemoglobin within red blood cells, where it binds and transports oxygen from the lungs to tissues via the ferrous (Fe²⁺) to ferric (Fe³⁺) redox cycle. Additional iron is found in myoglobin (muscle oxygen storage), cytochrome enzymes (mitochondrial electron transport chain), and numerous iron-sulfur cluster proteins critical for DNA synthesis, cellular respiration, and immune function. Iron homeostasis is tightly regulated through hepcidin — a hepatic peptide hormone that controls iron absorption from the duodenum and iron recycling by macrophages — because the body lacks an active excretory mechanism for iron.

Iron deficiency is the most common nutritional deficiency globally, affecting an estimated 1.2 billion people and manifesting along a spectrum from depleted stores (low ferritin) to iron deficiency anemia (reduced hemoglobin). Symptoms include fatigue, weakness, impaired cognitive function, exercise intolerance, restless legs, and compromised immunity. Populations at highest risk include menstruating women, pregnant women, endurance athletes (due to exercise-induced hemolysis and GI losses), vegetarians/vegans, and individuals with chronic inflammatory conditions. Diagnosis relies on a combination of serum ferritin, transferrin saturation, serum iron, and total iron-binding capacity, with ferritin below 30 ng/mL increasingly recognized as the threshold for functional deficiency even before anemia develops.

Supplemental iron comes in multiple forms with varying bioavailability and tolerability. Ferrous sulfate is the most commonly prescribed but frequently causes gastrointestinal side effects (nausea, constipation, dark stools). Better-tolerated alternatives include iron-bisglycinate (chelated iron with superior absorption and fewer GI effects), ferrous fumarate, and iron polysaccharide complex. Absorption is enhanced by vitamin-c (which reduces Fe³⁺ to the more absorbable Fe²⁺ form) and inhibited by calcium, phytates, tannins, and polyphenols. Every-other-day dosing has emerged as a strategy to optimize absorption by avoiding hepcidin-mediated suppression. Iron status interacts closely with copper (needed for ceruloplasmin-mediated iron oxidation), zinc, and vitamin-b-complex in comprehensive protocols for energy and blood health.

Mechanism of Action

Iron is an essential transition metal that exploits its ability to cycle between ferrous (Fe2+) and ferric (Fe3+) oxidation states to participate in critical biological redox reactions. Its most recognized function is oxygen transport: as the central atom in the heme prosthetic group of hemoglobin, iron reversibly binds oxygen in the lungs and releases it in peripheral tissues. Myoglobin, a related heme protein in muscle, stores oxygen for use during periods of high metabolic demand.

In the mitochondria, iron is a key component of the electron transport chain, present in cytochromes (as heme iron) and iron-sulfur cluster proteins. These proteins catalyze the sequential redox reactions that drive oxidative phosphorylation and ATP production. Iron also serves as an essential cofactor for numerous enzymes: ribonucleotide reductase (required for DNA synthesis), tyrosine hydroxylase and tryptophan hydroxylase (rate-limiting enzymes in catecholamine and serotonin synthesis), and prolyl/lysyl hydroxylases (necessary for collagen cross-linking).

Iron homeostasis is tightly regulated to prevent both deficiency and toxicity, as free iron catalyzes Fenton chemistry generating damaging hydroxyl radicals. The master regulator is hepcidin, a hepatic peptide hormone that binds to ferroportin—the only known cellular iron exporter—causing its internalization and degradation. This controls iron absorption from enterocytes, release from macrophages, and mobilization from hepatic stores. At the cellular level, iron regulatory proteins (IRP1/IRP2) sense intracellular iron and post-transcriptionally regulate ferritin (storage) and transferrin receptor (uptake) expression through iron-responsive elements (IREs) in their mRNAs.

Reconstitution Calculator

Research

Safety Profile

Safety Profile: Iron

Common Side Effects

• Gastrointestinal symptoms (affect 30–50% of users): nausea, constipation, diarrhea, abdominal cramping, and epigastric pain — most common reason for discontinuation
• Dark or black stools (harmless but alarming; distinguish from melena)
• Metallic taste and teeth staining (liquid preparations)
• Heartburn and acid reflux
• Loss of appetite

Serious Adverse Effects

• Acute iron toxicity (EMERGENCY): ingestion of >20 mg/kg elemental iron causes hemorrhagic gastroenteritis, metabolic acidosis, hepatic failure, cardiovascular collapse, and death; leading cause of pediatric poisoning fatality from supplements
• Iron overload (hemosiderosis/hemochromatosis): chronic excessive supplementation leads to iron deposition in liver (cirrhosis), heart (cardiomyopathy), pancreas (diabetes), and joints (arthropathy)
• Oxidative stress: excess free iron catalyzes Fenton reactions generating hydroxyl radicals; linked to accelerated atherosclerosis and increased cancer risk
• Anaphylaxis: primarily with IV iron formulations; rare with oral supplements
• GI ulceration and stricture: sustained-release formulations may cause localized mucosal erosions

Contraindications

• Hereditary hemochromatosis or iron-loading anemias (thalassemia major, sideroblastic anemia)
• Repeat blood transfusions causing secondary iron overload
• Active peptic ulcer disease or inflammatory bowel disease (may worsen GI inflammation)
• Hemolytic anemias (unless concurrent iron deficiency is confirmed)
• Parenteral iron: history of anaphylaxis to IV iron products

Drug Interactions

• Tetracyclines and fluoroquinolones: iron chelates these antibiotics, reducing absorption by 50–90%; separate dosing by 2–4 hours
• Levothyroxine: iron reduces thyroid hormone absorption; separate by at least 4 hours
• Levodopa / carbidopa: chelation reduces absorption and efficacy
• Antacids, PPIs, H2 blockers: reduced gastric acid decreases iron absorption (ferric forms most affected)
• Calcium supplements: competitive inhibition of iron absorption; avoid co-administration
• ACE inhibitors (captopril, enalapril): iron may reduce absorption; separate dosing
• Bisphosphonates: mutual absorption interference; separate by at least 2 hours

Population-Specific Considerations

• Pregnancy: iron requirements increase to 27 mg/day; deficiency causes preterm birth and low birth weight — but excess supplementation in iron-replete women may cause GDM and oxidative stress; check ferritin before supplementing
• Children: KEEP ALL IRON SUPPLEMENTS IN CHILDPROOF CONTAINERS; acute toxicity at >20 mg/kg is a medical emergency
• Elderly: anemia of chronic disease is common; iron supplementation without confirming true iron deficiency can cause harm; check ferritin and TIBC
• Menstruating individuals: most common population requiring supplementation; start with lowest effective dose to minimize GI effects
• Chronic kidney disease: complex iron metabolism; oral absorption often poor; IV iron may be preferred under nephrology guidance

Pharmacokinetic Profile